I’m excited to announce a new patient-centric partnership which will expand access to our therapies to people living with diabetes in Asia Pacific (APAC).
We are partnering with the world’s largest diabetes out-patient hospital – the Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) – to drive positive health outcomes for patients. As part of the agreement, we will provide pumps, consumables and professional CGM as well as complete therapy support for patients and health care providers, to help increase adoption of our therapies in the country.
We hope to start enrolling patients in September, with the goal of helping treat at least 1,000 patients over the next few years. The hospital currently has approximately 3 million registered diabetes patients and 5,000 patients seeking treatment daily, so we have the opportunity to scale up this partnership to reach many more patients in the future.
This partnership is a result of more than four years of engagement with Dr. Azad Khan, president of the Diabetic Association of Bangladesh (BADAS) and BIRDEM, and demonstrates our shared goals of driving better outcomes so that people living with diabetes can gain greater freedom and better health.